CN108339073A - 一种用于治疗皮肤不适的中草药提取液及其制备方法 - Google Patents
一种用于治疗皮肤不适的中草药提取液及其制备方法 Download PDFInfo
- Publication number
- CN108339073A CN108339073A CN201810476247.9A CN201810476247A CN108339073A CN 108339073 A CN108339073 A CN 108339073A CN 201810476247 A CN201810476247 A CN 201810476247A CN 108339073 A CN108339073 A CN 108339073A
- Authority
- CN
- China
- Prior art keywords
- ethyl alcohol
- extracts
- chinese herbal
- herbal medicine
- skin discomfort
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010040830 Skin discomfort Diseases 0.000 title claims abstract description 34
- 241000411851 herbal medicine Species 0.000 title claims abstract description 28
- 239000000284 extract Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 55
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 32
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims abstract description 30
- 235000019441 ethanol Nutrition 0.000 claims abstract description 28
- 229960004756 ethanol Drugs 0.000 claims abstract description 25
- 240000000774 Cunila origanoides Species 0.000 claims abstract description 16
- 235000018274 Cunila origanoides Nutrition 0.000 claims abstract description 16
- 235000014866 Dictamnus albus Nutrition 0.000 claims abstract description 16
- 241001671204 Stemona Species 0.000 claims abstract description 16
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 16
- 239000005711 Benzoic acid Substances 0.000 claims abstract description 15
- 241000218682 Pseudolarix amabilis Species 0.000 claims abstract description 15
- 229960004365 benzoic acid Drugs 0.000 claims abstract description 15
- 235000010233 benzoic acid Nutrition 0.000 claims abstract description 15
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 14
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 14
- 240000004980 Rheum officinale Species 0.000 claims abstract description 14
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 14
- 229940116229 borneol Drugs 0.000 claims abstract description 14
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 14
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229960002152 chlorhexidine acetate Drugs 0.000 claims abstract description 13
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000008213 purified water Substances 0.000 claims abstract description 11
- 239000003814 drug Substances 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 3
- 235000008216 herbs Nutrition 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 2
- 239000006228 supernatant Substances 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims 1
- 229960003260 chlorhexidine Drugs 0.000 claims 1
- 208000002474 Tinea Diseases 0.000 abstract description 14
- 201000004624 Dermatitis Diseases 0.000 abstract description 11
- 208000003251 Pruritus Diseases 0.000 abstract description 10
- 241000130764 Tinea Species 0.000 abstract description 9
- 230000001225 therapeutic effect Effects 0.000 abstract description 9
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 8
- 208000010668 atopic eczema Diseases 0.000 abstract description 6
- 201000004681 Psoriasis Diseases 0.000 abstract description 5
- 241000893966 Trichophyton verrucosum Species 0.000 abstract description 5
- 230000003628 erosive effect Effects 0.000 abstract description 5
- 241000222122 Candida albicans Species 0.000 abstract description 4
- 206010043866 Tinea capitis Diseases 0.000 abstract description 4
- 201000010618 Tinea cruris Diseases 0.000 abstract description 4
- 229940095731 candida albicans Drugs 0.000 abstract description 4
- 210000004761 scalp Anatomy 0.000 abstract description 4
- 208000009189 tinea favosa Diseases 0.000 abstract description 4
- 241000588724 Escherichia coli Species 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000007794 irritation Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 201000002266 mite infestation Diseases 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 206010012435 Dermatitis and eczema Diseases 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241001233914 Chelidonium majus Species 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241001645380 Bassia scoparia Species 0.000 description 1
- 235000016811 Biondella Nutrition 0.000 description 1
- 244000157790 Buglossoides arvense Species 0.000 description 1
- 235000004256 Buglossoides arvense Nutrition 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 241000244987 Daiswa polyphylla Species 0.000 description 1
- 241000522190 Desmodium Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 241000219099 Parthenocissus quinquefolia Species 0.000 description 1
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 description 1
- 241000132171 Phryma leptostachya Species 0.000 description 1
- 240000004064 Poterium sanguisorba Species 0.000 description 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 description 1
- 244000153955 Reynoutria sachalinensis Species 0.000 description 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 description 1
- 240000003152 Rhus chinensis Species 0.000 description 1
- 235000014220 Rhus chinensis Nutrition 0.000 description 1
- 241000219053 Rumex Species 0.000 description 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 241001530209 Swertia Species 0.000 description 1
- 240000006688 Telosma cordata Species 0.000 description 1
- 235000017352 Telosma cordata Nutrition 0.000 description 1
- 240000008488 Thlaspi arvense Species 0.000 description 1
- 235000008214 Thlaspi arvense Nutrition 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 235000001667 Vitex agnus castus Nutrition 0.000 description 1
- 244000063464 Vitex agnus-castus Species 0.000 description 1
- LPNITZFOZWXKMB-UHFFFAOYSA-N acetic acid;molecular chlorine Chemical compound ClCl.CC(O)=O LPNITZFOZWXKMB-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 229940105847 calamine Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229910052864 hemimorphite Inorganic materials 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 208000014265 psoriasis 10 Diseases 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种用于治疗皮肤不适的中草药提取液及其制备方法,包括苦参、土荆皮、大黄、百部、白鲜皮、醋酸氯己定、水杨酸、苯甲酸、冰片和乙醇,苦参1‑10%、土荆皮5‑15%、大黄1‑10%、百部5‑15%、白鲜皮1‑15%、醋酸氯己定0.05‑0.5%、水杨酸1‑5%、苯甲酸5‑10%、冰片0.1‑0.5%、乙醇30‑70%,余量为纯化水。该用于治疗皮肤不适的中草药提取液及其制备方法,能治疗脚痒、脚臭、脚起泡、脚糜烂、牛皮癣、体癣、股癣、头癣、手足癣、皮炎、湿疹等症状,抑制大肠杆菌,金黄色葡萄球菌和白色念珠菌等引起的皮肤不适问题,且疗效显著,温和不刺激,治疗效果显著,不易复发。
Description
技术领域
本发明属于中草药提取液技术领域,具体涉及一种用于治疗皮肤不适的中草药提取液及其制备方法。
背景技术
市场上治疗皮肤不适的产品中,对皮肤的刺激性大,易复发。如专利公开号CN103341104A,公开日20131009公开的一种治疗皮肤病的外用中药,本发明药物有膏剂、酊剂组成,其膏剂组成苦参、紫花地丁、黄连、黄柏、大黄、白鲜皮、紫草、蚤休、蛇床子、败酱草、白蔹、地肤子、徐长卿、白芷、当归、没药、侧柏叶、三七、露蜂房、硼砂、炉甘石、凡士林、羊毛脂、十八醇;其酊剂组成百部、金钱草、虎杖、透骨草、地榆、土荆皮、土大黄、五倍子、徐长卿、龙胆草、苯甲酸、水杨酸、75%乙醇,本发明具有清热解毒、凉血活血、祛斑化瘀、散风除湿、抑菌杀菌、消炎止痒、祛风润燥杀虫之功效,对银屑病、湿疹、皮炎、体癣、手足癣、花斑癣、疥疮等皮肤病有较好的疗效。而且该发明药物的禁忌较多:
1、皮肤破损出血时慎用;
2、对本品过敏者禁用;
3、孕妇和儿童慎用;
4、本品只用于外用,不能内服;
5、如本品不慎误入眼中,请立即用大量清水冲洗,如不缓解,尽快到最近医院处理。
该发明药物用时应注意事项:忌食酸、辣、腥、烟、酒等刺激性食物。
为此需要一种温和不刺激,治疗效果显著的植物精髓萃取。
发明内容
本发明的目的就在于为了解决上述问题而提供一种用于治疗皮肤不适的中草药提取液及其制备方法,温和不刺激,治疗效果显著。
本发明通过以下技术方案来实现上述目的:
一种用于治疗皮肤不适的中草药提取液,其原料药包括苦参、土荆皮、大黄、百部、白鲜皮、醋酸氯己定、水杨酸、苯甲酸、冰片和乙醇。
作为本发明的进一步优化方案,其原料药按重量份制成:苦参1-10%、土荆皮5-15%、大黄1-10%、百部5-15%、白鲜皮1-15%、醋酸氯己定0.05-0.5%、水杨酸1-5%、苯甲酸5-10%、冰片0.1-0.5%、乙醇30-70%,余量为纯化水。
作为本发明的进一步优化方案,其原料药按重量份制成:苦参5%、土荆皮5%、大黄2.5%、百部5%、白鲜皮5%、醋酸氯己定0.15%、水杨酸3%、苯甲酸6%、冰片0.2%,乙醇50%、纯化水18.15%。
根据上述的用于治疗皮肤不适的中草药提取液的制备方法,将苦参、土荆皮、大黄、百部、白鲜皮五味药材,置于提取罐中,加乙醇提取两次,第一次加10-15倍量乙醇提取1-5小时,第二次加5-10倍量乙醇提取1-5小时,合并乙醇溶液,滤过,静置24-48小时,取上清液,回收乙醇至含醇量为30-70%,加入相应比例的醋酸氯己定、苯甲酸、水杨酸、冰片和纯化水,混匀。
药理作用:
苦参,清热燥湿、杀虫,治皮肤瘙痒,疥癞恶疮;
土荆皮,治疥癣;
大黄,邪热毒,破积滞,行淤血,治痈疡肿毒;
百部,杀虫,治皮肤疥癣;
白鲜皮,具有祛风、燥湿、清热、解毒之功效,治风热疮毒、疥癣、皮肤痒痛等症,为治牛皮癣之要药,《药性论》云:“治一切热毒风、恶风、风疮、疥癣赤烂”;
醋酸氯己定有抑杀需氧菌的作用;
水杨酸、苯甲酸,都具有软化和溶解角质、抑制真菌、止痒的功效;
本发明的有益效果在于:
1)本发明能治疗脚痒、脚臭、脚起泡、脚糜烂、牛皮癣、体癣、股癣、头癣、手足癣、皮炎、湿疹等症状,抑制大肠杆菌,金黄色葡萄球菌和白色念珠菌等引起的皮肤不适问题,且疗效显著;
2)本发明,温和不刺激,治疗效果显著,不易复发。
具体实施方式
下面结合实施例对本发明作进一步说明:
实施例一
1、材料:
本实施例所用方法如无特别说明均为本领域的技术人员所知晓的常规方法,所用的试剂等材料,如无特别说明,均为市售购买产品。
一种用于治疗皮肤不适的中草药提取液,其原料药按重量份制成:苦参1%、土荆皮5%、大黄1%、百部15%、白鲜皮15%、醋酸氯己定0.05%、水杨酸1%、苯甲酸5%、冰片0.1%,纯化水56.85%。
2、方法
用于治疗皮肤不适的中草药提取液的制备
将苦参、土荆皮、大黄、百部、白鲜皮五味药材,置于提取罐中,加乙醇提取两次,第一次加10-15倍量乙醇提取1-5小时,第二次加5-10倍量乙醇提取1-5小时,合并乙醇溶液,滤过,静置24-48小时,取上清液,回收乙醇至含醇量为30-70%,加入相应比例的醋酸氯己定、苯甲酸、水杨酸、冰片和纯化水,混匀。
3、临床验证
准备临床验证,具体如下:
选取若干患者病理,包括脚痒10例、脚臭10例、脚起泡10例、脚糜烂10例、牛皮癣10例、体癣10例、股癣10例、头癣10例、手足癣10例、皮炎8例、湿疹8例、大肠杆菌引起皮肤不适8例、引起皮肤不适金黄色葡萄球菌引起皮肤不适5例、白色念珠菌引起皮肤不适6例,采用用于治疗皮肤不适的中草药提取液进行涂抹或喷液治疗,每天使用2-3次,统计临床治疗结果。
表1:用于治疗皮肤不适的中草药提取液临床实验结果统计表
临床实验可看出,该用于治疗皮肤不适的中草药提取液,对脚痒、脚臭、脚起泡、牛皮癣、体癣、股癣、头癣、手足癣的治疗效果显著;有效的治疗脚糜烂、皮炎和湿疹;对大肠杆菌、金黄色葡萄球菌或白色念珠菌等引起的皮肤不适问题有着非常显著的治疗效果;实验患者中均未出现任何副作用,且实验患者在治疗过程中,均没有刺激性感受,用户反馈均为温和不刺激。
实施例二,一种用于治疗皮肤不适的中草药提取液,其原料药按重量份制成:苦参5%、土荆皮5%、大黄2.5%、百部5%、白鲜皮5%、醋酸氯己定0.15%、水杨酸3%、苯甲酸6%、冰片0.2%,乙醇50%、纯化水18.15%,该用于治疗皮肤不适的中草药提取液的制备方法同实施例一。
选取若干患者病理,包括脚痒10例、脚起泡10例、脚糜烂10例、手足癣10例、皮炎8例、湿疹8例、金黄色葡萄球菌引起皮肤不适5例,采用用于治疗皮肤不适的中草药提取液进行涂抹或喷液治疗,每天使用2-3次,统计临床治疗结果。
表2:用于治疗皮肤不适的中草药提取液临床实验结果统计表
临床实验可看出,该用于治疗皮肤不适的中草药提取液,对脚痒、脚起泡、手足癣、黄色葡萄球菌引起的皮肤不适问题的治疗效果显著;有效的治疗脚糜烂、皮炎和湿疹;实验患者中均未出现任何副作用,且实验患者在治疗过程中,均没有刺激性感受,用户反馈均为温和不刺激。
实施例三,一种用于治疗皮肤不适的中草药提取液,其原料药按重量份制成:苦参10%、土荆皮15%、大黄10%、百部5%、白鲜皮1%、醋酸氯己定0.5%、水杨酸5%、苯甲酸10%、冰片0.5%、纯化水43%,该用于治疗皮肤不适的中草药提取液的制备方法同实施例一。
选取若干患者病理,包括脚痒10例、脚起泡10例、脚糜烂10例、手足癣10例、皮炎8例、湿疹8例、金黄色葡萄球菌引起皮肤不适5例,采用用于治疗皮肤不适的中草药提取液进行涂抹或喷液治疗,每天使用2-3次,统计临床治疗结果。
表3:用于治疗皮肤不适的中草药提取液临床实验结果统计表
临床实验可看出,该用于治疗皮肤不适的中草药提取液,对脚痒、脚起泡、手足癣的治疗效果显著;有效的治疗脚糜烂、皮炎和湿疹;对金黄色葡萄球菌引起的皮肤不适问题有着非常显著的治疗效果;实验患者中均未出现任何副作用,且实验患者在治疗过程中,均没有刺激性感受,用户反馈均为温和不刺激。
以上为本发明一种详细的实施方式和具体的操作过程,是以本发明技术方案为前提下进行实施,但本发明的保护范围不限于上述的实施例。
Claims (4)
1.一种用于治疗皮肤不适的中草药提取液,其特征在于:其原料药包括苦参、土荆皮、大黄、百部、白鲜皮、醋酸氯己定、水杨酸、苯甲酸、冰片和乙醇。
2.根据权利要求1所述的一种用于治疗皮肤不适的中草药提取液,其特征在于是,其原料药按重量份制成:苦参1-10%、土荆皮5-15%、大黄1-10%、百部5-15%、白鲜皮1-15%、醋酸氯己定0.05-0.5%、水杨酸1-5%、苯甲酸5-10%、冰片0.1-0.5%、乙醇30-70%,余量为纯化水。
3.根据权利要求1所述的一种用于治疗皮肤不适的中草药提取液,其特征在于,其原料药按重量份制成:苦参5%、土荆皮5%、大黄2.5%、百部5%、白鲜皮5%、醋酸氯己定0.15%、水杨酸3%、苯甲酸6%、冰片0.2%,乙醇50%、纯化水18.15%。
4.根据权利要求1-3任意一项所述的用于治疗皮肤不适的中草药提取液的制备方法,其特征在于,将苦参、土荆皮、大黄、百部、白鲜皮五味药材,置于提取罐中,加乙醇提取两次,第一次加10-15倍量乙醇提取1-5小时,第二次加5-10倍量乙醇提取1-5小时,合并乙醇溶液,滤过,静置24-48小时,取上清液,回收乙醇至含醇量为30-70%,加入相应比例的醋酸氯己定、苯甲酸、水杨酸、冰片和纯化水,混匀。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810476247.9A CN108339073A (zh) | 2018-05-17 | 2018-05-17 | 一种用于治疗皮肤不适的中草药提取液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810476247.9A CN108339073A (zh) | 2018-05-17 | 2018-05-17 | 一种用于治疗皮肤不适的中草药提取液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108339073A true CN108339073A (zh) | 2018-07-31 |
Family
ID=62956404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810476247.9A Pending CN108339073A (zh) | 2018-05-17 | 2018-05-17 | 一种用于治疗皮肤不适的中草药提取液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108339073A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111166841A (zh) * | 2020-01-06 | 2020-05-19 | 成都润兴消毒药业有限公司 | 一种皮肤消毒组合药剂及其制备方法和使用方法 |
CN113116977A (zh) * | 2019-12-31 | 2021-07-16 | 郑州维谊生物科技有限公司 | 一种用于治疗真菌感染的洗浴粉及其制备方法 |
CN115414450A (zh) * | 2022-09-19 | 2022-12-02 | 江西中科佰氏药业有限公司 | 一种含多种中药的皮肤外用抑菌乳膏及制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102018796A (zh) * | 2010-06-25 | 2011-04-20 | 杭州易舒特药业有限公司 | 免冲洗浓缩型澄清中药止痒洗剂 |
CN104510955A (zh) * | 2013-10-07 | 2015-04-15 | 青岛联合创新技术服务平台有限公司 | 一种用于治疗脚气的中药组方 |
CN107812137A (zh) * | 2017-10-25 | 2018-03-20 | 北京中蜜科技发展有限公司 | 一种含蜂胶的草本皮肤抑菌凝胶及其制备方法 |
-
2018
- 2018-05-17 CN CN201810476247.9A patent/CN108339073A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102018796A (zh) * | 2010-06-25 | 2011-04-20 | 杭州易舒特药业有限公司 | 免冲洗浓缩型澄清中药止痒洗剂 |
CN104510955A (zh) * | 2013-10-07 | 2015-04-15 | 青岛联合创新技术服务平台有限公司 | 一种用于治疗脚气的中药组方 |
CN107812137A (zh) * | 2017-10-25 | 2018-03-20 | 北京中蜜科技发展有限公司 | 一种含蜂胶的草本皮肤抑菌凝胶及其制备方法 |
Non-Patent Citations (3)
Title |
---|
安徽华康药业有限公司: "安徽华康药业有限公司企业标准—肤施乐抑菌液", 《企业标准信息公共服务平台》 * |
毛新贵等: "股癣净擦剂的研制和应用", 《中国疗养医学》 * |
田丽颖等: "自拟阴道擦洗方治疗顽固性霉菌性阴道炎51例", 《安徽中医临床杂志》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113116977A (zh) * | 2019-12-31 | 2021-07-16 | 郑州维谊生物科技有限公司 | 一种用于治疗真菌感染的洗浴粉及其制备方法 |
CN111166841A (zh) * | 2020-01-06 | 2020-05-19 | 成都润兴消毒药业有限公司 | 一种皮肤消毒组合药剂及其制备方法和使用方法 |
CN115414450A (zh) * | 2022-09-19 | 2022-12-02 | 江西中科佰氏药业有限公司 | 一种含多种中药的皮肤外用抑菌乳膏及制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6027728A (en) | Herbal skin regeneration composition and method | |
CN106334067B (zh) | 含银离子抗菌剂的妇科凝胶、制备方法及应用 | |
CN106109534B (zh) | 含银离子抗菌剂的止痒修复液、制备方法及应用 | |
CN102512490A (zh) | 一种治疗妇科炎症的香薰精油及其精油香薰贴 | |
CN108339073A (zh) | 一种用于治疗皮肤不适的中草药提取液及其制备方法 | |
CN102327343B (zh) | 预防与治疗脚气的外用精油 | |
CN108671163B (zh) | 复方中药抗菌组合物及其在洗护产品中的应用 | |
CN1161199A (zh) | 苦参洗浴液 | |
CN105311601A (zh) | 一种驱虫的中药组合物 | |
CN102885883B (zh) | 淋巴排毒复方精油 | |
CN1175427A (zh) | 一种可治疗创面的中药喷剂及油纱 | |
CN102755573A (zh) | 一种治疗灰指甲的外用中药 | |
CN113332350A (zh) | 一种复方本草抑菌液及其制备工艺、应用 | |
Ibegbu et al. | Anti-inflammatory effects of the aqueous Extracts of plantain roots (Musa Species) | |
CN104840647A (zh) | 一种妇科清洗消毒液配方 | |
JP6590233B1 (ja) | 皮膚疾患治療剤及びその製造方法 | |
CN111803603A (zh) | 一种用于治疗蚊虫叮咬引起的皮肤病及细菌病毒的药剂 | |
CN106421511A (zh) | 一种芦荟抑菌组合物及其制备方法 | |
CN104189741A (zh) | 治疗牛皮癣中药椒艾合剂及其应用方法 | |
CN104491240A (zh) | 中草药杀菌剂 | |
CN111166841B (zh) | 一种皮肤消毒组合药剂及其制备方法和使用方法 | |
CN104436116B (zh) | 一种迷迭香足浴粉及其制备方法 | |
Guba | Toxicity myths: the actual risks of essential oil use | |
CN1047080C (zh) | 治疗股癣、肛门瘙痒、皮炎等病的药物制备方法 | |
CN102416068B (zh) | 一种清洁护肤组合物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180731 |